Shu, Y., Tao, Q., Xu, Q., Chen, Y., Xu, Y., Ma, T., . . . Shi, Y. (2025). Loss of NUMB promotes hepatomegaly and hepatocellular carcinoma through the AKT/glycogen/hippo signaling. Oncogene, 1. https://doi.org/10.1038/s41388-025-03430-z
Chicago-referens (17:e uppl.)Shu, Yuke, et al. "Loss of NUMB Promotes Hepatomegaly and Hepatocellular Carcinoma Through the AKT/glycogen/hippo Signaling." Oncogene 2025: 1. https://doi.org/10.1038/s41388-025-03430-z.
MLA-referens (9:e uppl.)Shu, Yuke, et al. "Loss of NUMB Promotes Hepatomegaly and Hepatocellular Carcinoma Through the AKT/glycogen/hippo Signaling." Oncogene, 2025, p. 1, https://doi.org/10.1038/s41388-025-03430-z.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
